Effects of Ginkgo biloba Extract on the Oral Bioavailability of Fluoxetine and Venlafaxine in Rats

Fatima Adnan Alzubaidi; Saad Abdulrahman Hussain

American Journal of Pharmacological Sciences. 2015, 3(1), 7-12
DOI: 10.12691/ajps-3-1-2

Open AccessArticle

Effects of Ginkgo biloba Extract on the Oral Bioavailability of Fluoxetine and Venlafaxine in Rats

Fatima Adnan Alzubaidi¹ and Saad Abdulrahman Hussain^2,

¹Department of Pharmacology, College of Pharmacy, University of Babylon, Babylon, Iraq

²Department of Pharmacology and Toxicology, College of Pharmacy, University of Baghdad, Baghdad, Iraq

Pub. Date: January 18, 2015

View Full Text Full Text PDF Full Text ePUB

Cite this paper:
Fatima Adnan Alzubaidi and Saad Abdulrahman Hussain. Effects of Ginkgo biloba Extract on the Oral Bioavailability of Fluoxetine and Venlafaxine in Rats. American Journal of Pharmacological Sciences. 2015; 3(1):7-12. doi: 10.12691/ajps-3-1-2

Abstract

Since herbal supplements are not evaluated for interactions with other drugs, there are concerns about their interactions with conventional drugs, which are mostly used as multiple drug treatment approach. The present study aims to evaluate the effects of long-term use of Ginkgo biloba (GK) extract on the intestinal absorption of orally administered, single doses of fluoxetine and venlafaxine in rats. AUC calculations and cumulative diffused calculations are utilized for evaluation of physicochemical interactions in vitro. Rats administered 100 and 200 mg/kg of GK extract, and oral bioavailability of single doses of fluoxetine and venlafaxine were evaluated using HPLC method. The results showed that GK extract has no significant effects on the bioavailability of fluoxetine and venlafaxine. Fluoxetine and venlafaxine serum levels are not affected by 100 mg/kg GK extract, while 200 mg/kg significantly increases venlafaxine level, with no effect on that of fluoxetine. In conclusion, GK extract shows no physicochemical interactions with fluoxetine or venlafaxine. Long-term administration of a low dose of GK extract (100 mg/kg) had no significant effect on serum levels of fluoxetine and venlafaxine, while lager dose (200 g/kg) increases significantly only the serum level of venlafaxine, while that of fluoxetine was not affected.

Keywords:
Ginkgo biloba fluoxetine venlafaxine oral availability drug interaction

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Bardia A, Nisly NL, Zimmerman MB, Gryzlak BM, Wallace RB. Use of herbs among adults based on evidence-based indications: findings from the National Health Interview Survey. Mayo Clin. Proc., 82: 561-566. 2007.

[2]	Gardiner P, Phillips R, and Shaughnessy AF. Herbal and dietary supplement-drug interactions in patients with chronic illnesses. Am. Fam. Physician, 77: 73-78. 2008.

[3]	Mohamed MF, Frye RF.Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids. Drug Metab. Dispos., 38 (2): 270-275. 2012.

[4]	Zhao XD, Dong N, Man HT, Fu ZL, et al. Antiproliferative effect of the Ginkgo biloba extract is associated with the enhancement of cytochrome P450 1B1 expression in estrogen receptor‑negative breast cancer cells. Biomed. Rep., 1 (5): 797-801. 2013.

[5]	American Herbal Pharmacopoeia. Gingko Leaf & Ginkgo Leaf Dry Extract Monograph. Santa Cruz: American Herbal Pharmacopoeia, 2003.

[6]	Pilija V, Mirjana R, Brenesel MD, Popovic M, et al. Inhibitory effect of Ginkgo Biloba extract on the tonus of the small intestine and the colon of rabbits. Molecules, 15: 2079-2086. 2010.

[7]	He L, Guoying Z, Xu J, Liu, J, et al. Research progress on polysaccharides from Ginkgo biloba.J. Med. Plants Res., 6: 171-176. 2012.

[8]	Robertson SM, Davey RT, Voell J, Formentini E, et al. Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects. Curr. Med. Res. Opin., 24 (2): 591-599. 2008.

[9]	Abad MJ, Bedoya LM, Bermejo P.An update on drug interactions with the herbal medicine Ginkgo biloba. Curr. Drug Metab., 11: 171-181. 2010.

[10]	Fan L, Tao GY, Wang G, Chen Y, et al. Effects of Ginkgo biloba extract ingestion on the pharmacokinetics of talinolol in healthy Chinese volunteers. Ann. Pharmacother., 43: 944-949. 2009.

[11]	Fan L, Mao XQ, Tao GY, Wang G, et al. Effect of Schisandrachinensis extract and Ginkgo biloba extract on the pharmacokinetics of talinolol in healthy volunteers. Xenobiotica, 39: 249-254. 2009.

[12]	Hellum BH, Nilsen OG. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin. Pharmacol. Toxicol., 102:466-475. 2008.

[13]	Nuhu AA. Ginkgo biloba: A ‘living fossil’ with modern day phytomedicinal applications. J. Appl. Pharm. Sci., 4 (3): 96-103. 2014.

[14]	Pal D, Mitra AK. MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci., 78: 2131-2145. 2006.

[15]	Rao V, Raj MK, Ravinder S, Sowmya K, Kumar KP, Sudhakar M.Effect of Permeation enhancers on diffusion of lamotrigine drug through cellophane membrane. Am. J. Adv. Drug Deliv., 1 (4): 606-610. 2013.

[16]	Eswarudu MM, Anitha M, Gayathri N, chaithanya T. A validated RP-HPLC method for the simultaneous estimation of fluoxetine hydrochloride and olanzapine in pharmaceutical dosage form.Int. Res. J. Pharmacy., 3 (4): 310-313. 2012.

[17]	Caccia S, Cappi MC, Garattini S. Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat. Psychopharmacology, 100 (4): 509-514. 1990.

[18]	Eren I, Naziroglu M, Demirdas A, Celik O, et al. Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem. Res., 32 (3): 497-505. 2007.

[19]	Abeer MA, Maha AA. Histological study of prolonged exposure to mobile phone radiations on young male albino rat's cerebellar cortex and the role of Ginkgo biloba supplementation. J. Am. Sci., 9 (11): 156-166. 2013.

[20]	Kirchengast M. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond. J. Hypertens., 15 (2): S27-S33. 1997.

[21]	Keller T, Cambon N, Genevray M, Crivelli F, et al. Bioequivalence study of fluoxetine hydrochloride in healthy volunteers. Arzneimittelforschung, 2005; 55 (9): 491-497. 2005.

[22]	Goodnick PJ. Pharmacokinetic optimization of therapy with newer anti-depressants. Clin. Pharmacokinet., 27 (4): 307-330. 1994.

[23]	Cheng CL, Chou CH. Determination of metformin in human plasma by high-performance liquid chromatography with spectrophotometric detection. J. Chromatography B, 762: 51-58. 2001.

[24]	Ji HY, Liu KH, Kong TY, Jeong HU, et al. Evaluation of DA-9801, a new herbal drug for diabetic neuropathy, on metabolism-mediated interaction. Arch. Pharm. Res., 36: 1-5. 2013.

[25]	McKay DL, Chen CO, Yeum KJ, Matthan NR, et al. Chronic and acute effects of walnuts on antioxidant capacity and nutritional status in humans: a randomized, cross-over pilot study. Nutr. J., 9: 21. 2010.

[26]	Mandel SA, Amit T, Kalfon L, Reznichenko L, Youdim MB. Targeting multiple neurodegenerative diseases etiologies with multimodal-acting green tea catechins. J. Nutr., 138: 1578S-1583S. 2008.

[27]	Hou RR, Chen JZ, Chen H, Kang XG, et al. Neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis in PC12 cells. Cell. Biol. Int., 32 (1): 22-30. 2008.

[28]	Jaccob AA, Hussain SA. Effects of long-term use of flavonoids on the absorption and tissue distribution of orally administered doses of trace elements in rats. Pharmacol. Pharmacy, 3 (4): 474-480. 2012.

[29]	Choi YH, Chin YW, Kim YG. Herb-drug interactions: focus on metabolic enzymes and transporters. Arch. Pharm. Res., 34: 1843-1863. 2011.

[30]	Na DH, Ji HY, Park EJ, Kim MS, et al. Evaluation of metabolism-mediated herb-drug interactions. Arch. Pharmacol. Res., 34 (11): 1829-1842. 2011.

[31]	Samson RR. Effects of dietary garlic and temporal drift on platelet aggregation. Atherosclerosis, 44 (1): 119-120. 1982.

[32]	Perlman BB. Interaction between lithium salts and ispaghula husk. Lancet, 335 (8686): 416. 1990.

[33]	Bachmeier C, Levin GM, Abdelahad DB, et al. Effect of Venlafaxine and Desvenlafaxine on drug efflux protein expression and biodistribution in vivo. J. Pharm. Sci., 102: 3838-3843. 2013.

[34]	Najafzadeh H, Fatemi SR, Ashna A. Effect of verapamil on serum level of salinomycin in diabetic rats. Am. J. Appl. Sci., 8 (9): 860-863. 2011.

[35]	Doran A, Obach RS, Smith BJ, Hosea NA, et al. The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model. Drug Metab. Dispos., 33: 165-174. 2005.

[36]	Shugarts S, Benet LZ. The role of transporters in the pharmacokinetics of orally administered drugs. Pharm. Res., 26 (9): 2039-2054. 2009.

[37]	Bansal T, Mishra G, Jaggi M, Khar RK, Talegaonkar S. Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats. Eur. J. Pharm. Sci., 36 (4-5): 580-590. 2009.

[38]	De Klerk OL, Willemsen AT, Bosker FJ, Bartels AL, et al. Regional increase in P-glycoprotein function in the blood brain barrier of patients with chronic schizophrenia: A PET study with [¹¹C]-verapamil as a probe for P-glycoprotein function. Psychiatry Res., 183: 151-156. 2010.

[39]	Milane A, Fernandez C, Vautier S, Bensimon G, et al. Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier. J. Neurochem., 103: 164-173. 2007.

[40]	Adlersberg S, Toren P, Mester R, Rehavi M, et al. Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants. Clin. Neuropharmacol., 17: 294-297. 1994.

[41]	Aszalos A, Thompson K, Yin JJ, Ross DD. Combinations of P-glycoprotein blockers, verapamil, PSC833, and cremophor act differently on the multidrug resistance associated protein (MRP) and on P-glycoprotein (Pgp). Anticancer Res., 19: 1053-1064. 1999.

[42]	Yang CY, Chao PD, Hou YC, Tsai SY, et al. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats. Food Chem. Toxicol., 44: 1572-1578. 2006.

[43]	Uchida S, Yamada H, Li XD, Maruyama S, et al. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers. J. Clin. Pharmacol., 46: 1290-1298. 2006.

[44]	Song IS, Kong TY, Jeong HU, Kim EN, et al. Evaluation of the transporter-mediated herb-drug interaction potential of DA-9801, a standardized dioscorea extract for diabetic neuropathy, in human in vitro and rat in vivo. BMC Complment. Altern. Med., 14: 251-259. 2014.